BioMed Central

Morris Animal Foundation: Human noise negatively impacts cricket survival, reproduction

Retrieved on: 
Thursday, May 2, 2024
Morris Animal Foundation, University, Survival, University of Denver, DU, Research, Ecology, Human, Female, Zoological medicine, Invertebrate, Noise, Louisiana State University, Associate, Atmosphere, BioMed Central

DENVER, May 2, 2024 /PRNewswire/ -- As the sun sets and the sweltering heat gives way to a balmy evening, there's one sound that fills the air, both beloved and bothersome: the rhythmic symphony of chirping crickets. However, human-generated noise can mask the harmony of the cricket song, prompting researchers to question if it is also drowning out the melody.

Key Points: 
  • However, human-generated noise can mask the harmony of the cricket song, prompting researchers to question if it is also drowning out the melody.
  • University of Denver researchers, in a study funded by Morris Animal Foundation, evaluated the impact of human-generated noise on crickets.
  • Vehicular noise exposes at least 83% of land in the continental U.S., and 88% of people experience noise equivalent to constant rainfall.
  • "The research provides important insight into the impact of anthropogenic activity (traffic noise) on the immune and reproductive responses of an invertebrate (cricket)," he said.

Baseline Enrollment Completed for AMRA Medical and Linköping University’s Landmark Liver Disease Study

Retrieved on: 
Thursday, April 25, 2024
Surgery, Medical Devices, Hospitals, Science, Fitness & Nutrition, Clinical Trials, Cardiology, Diabetes, Biotechnology, Health, Health Technology, Research, University, Education, Radiology, Pharmaceutical, Oncology, Mortality, Social stigma, Gastroenterology, Liver disease, Contraindication, MFI, Cachexia, Hepatocellular carcinoma, BioMed Central, Body composition, Patient, HMV, Medicine, Fatty liver disease, Cirrhosis, MRI, Public health surveillance, Multimedia, Diagnosis, Manuscript, Biomarker, Portal hypertension, Quality of life, Ageing, Medical imaging

The nationally-comprised study population includes 150 liver cirrhosis patients aged 18 and up, with no liver transplant history or contraindications to performing an MRI examination, enrolled from one of three Swedish liver care clinics located in Linköping, Eksjö, or Jönköping.

Key Points: 
  • The nationally-comprised study population includes 150 liver cirrhosis patients aged 18 and up, with no liver transplant history or contraindications to performing an MRI examination, enrolled from one of three Swedish liver care clinics located in Linköping, Eksjö, or Jönköping.
  • Over a duration of 2 years, patients will be assessed every 6 months with a comprehensive clinical examination and a whole-body MRI examination.
  • AMRA’s muscle volume (MV) and muscle fat infiltration (MFI) measures have previously been shown to independently predict all-cause mortality 1 and comorbid vulnerability 2 in patients with fatty liver disease.
  • The full manuscript detailing the ACCESS-ESLD study design and objectives was recently published in the journal BMC Gastroenterology in late 2023.

Phytopathology Research Celebrates 100 Years of Plant Pathology Research in China

Retrieved on: 
Thursday, April 18, 2024
Tao, Agriculture, Springer Nature, Plant, Teaching, Collection, Research, Pathology, History, Fungal infection, BioMed Central, Nanjing Agricultural University, Wheat diseases, Immunity, Knowledge

BEIJING, April 18, 2024 /PRNewswire/ -- Plant pathology or phytopathology is a scientific study discipline focusing on plant diseases caused by pathogens and environmental factors. In China, the teaching of plant pathology commenced in 1910. Despite its relatively brief history, China's phytopathology research community has grown into a force to reckon with, contributing immensely to the body of scientific knowledge over 100 fruitful years—a feat that calls for celebrations!

Key Points: 
  • The esteemed journal published a special issue on plant pathology research in China, covering topics from plant diseases to immunity
    BEIJING, April 18, 2024 /PRNewswire/ -- Plant pathology or phytopathology is a scientific study discipline focusing on plant diseases caused by pathogens and environmental factors.
  • Accordingly, Phytopathology Research —a leading open-access journal from BioMed Central (part of Springer Nature) that publishes cutting-edge applied and fundamental plant pathology research—brought out a special issue, " Plant Pathology Research in China: A Centennial View ," on 6 April 2022.
  • Notably, the collection comprised comprehensive editorials and reviews about diverse topics related to plant pathology in the context of China.
  • Prof. Liu concludes, "The knowledge gained from plant pathology research has helped achieve sustainable agriculture in China, apart from its global impact."

AION Labs, In Continued Partnership with BioMed X, Launches First 2024 Global Call for Applications: AI/ML Platform for Targeting RNA with Small Molecules

Retrieved on: 
Tuesday, February 20, 2024
Merck, Amazon Web Services, Chemistry, AI, RNA, Invention, AION, BioMed Central, Research, AWS, Vaccine

REHOVOT, Israel and HEIDELBERG, Germany, Feb. 20, 2024 /PRNewswire/ -- AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X, announced today the launch of its latest global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs' headquarters in Rehovot, Israel.

Key Points: 
  • AION Labs' next startup will focus on the development of an AI/ML computational platform to identify functional regions in RNA that can be targeted with small molecules.
  • However, recent developments have shown that RNA levels can be modulated using small molecules, which has resulted in several candidate drugs currently in clinical trials.
  • RNA targeting is an emerging field and small molecule discovery of RNA modulators remains a significant challenge.
  • Further details about this call for applications can be found on the AION Labs website: www.aionlabs.com .

Sahmyook University Researchers Developed Hip-Assist Robot to Advance Fitness in the Elderly

Retrieved on: 
Thursday, February 15, 2024
Robotics, BioMed Central, Ratio, Research, Geriatrics, Samsung Electronics, Walking, Exercise, Risk, Facial muscles, Sahmyook University, TUG, Science, Movement, Comparison, RUSI, Gangsta Walking

Recently, researchers from Sahmyook University in Korea have developed EX1, an exercise assistance robot, with the goal to amplify physical function and strength in senior individuals.

Key Points: 
  • Recently, researchers from Sahmyook University in Korea have developed EX1, an exercise assistance robot, with the goal to amplify physical function and strength in senior individuals.
  • Led by Professor Wan-hee Lee from Sahmyook University College of Health Science, Korea, a collaborative team of researchers, Noble County, and Samsung Electronics, assessed the effectiveness of EX1 in executing a four-week combined exercise program for older adults.
  • This will further expand the global wearable robot market, promoting further research and commercialization," concludes an optimistic Prof. Lee.
  • Title of original paper:    Effect of 4–weeks exercise program using wearable hip–assist robot (EX1) in older adults: one group pre– and post– test

AION Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery

Retrieved on: 
Tuesday, January 30, 2024
Disease, AION, Patient, Biology, Research, Deep learning, Amazon Web Services, Computational biology, BioMed Central, University, AI, Algorithm, AWS, Protein, Doctor of Philosophy, Machine learning, Merck, Treatment, Data science, Weizmann Institute of Science, Medical device

REHOVOT, Israel , Jan. 30, 2024 /PRNewswire/ -- AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced today the formation of TenAces Biosciences. TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning  to enhance development of treatments for a range of conditions.

Key Points: 
  • TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning  to enhance development of treatments for a range of conditions.
  • TenAces emerged from AION Labs' fifth startup challenge to develop an AI platform to identify naturally occurring protein interactions leading to targeted protein degradation.
  • The platform solution is expected to facilitate the discovery and development of molecular glue therapies for enhanced targeted protein degradation.
  • TenAces is taking a different approach, by applying machine learning to study the various interactions, protein pairs, and multi-dimensional features to predict new molecular glues.

BioMed Diagnostics to Attend VMX 2024

Retrieved on: 
Tuesday, January 9, 2024
Yeast, Learning, Food, Animal, VMX, Culture, BioMed Central, Orange County Convention Center, Dermatophyte, Environment, Tritrichomonas foetus, Bacteria, Human, Veterinarian, Growth

ORLANDO, Fla., Jan. 9, 2024 /PRNewswire/ -- BioMed Diagnostics, a leader in microbiological testing and a DCN Dx brand, is pleased to announce their attendance at VMX 2024, the world's leading veterinary expo and conference. While not exhibiting, BioMed representatives have set aside availability for meeting with veterinary professionals and attendees throughout the event.

Key Points: 
  • ORLANDO, Fla., Jan. 9, 2024 /PRNewswire/ -- BioMed Diagnostics, a leader in microbiological testing and a DCN Dx brand, is pleased to announce their attendance at VMX 2024 , the world's leading veterinary expo and conference.
  • Highlighting their commitment to veterinary health, BioMed representatives will discuss several key products at VMX 2024, including:
    InTray® DM: An enriched dermatophyte medium for detecting dermatophytes from clinical specimens.
  • Veterinary professionals interested in learning more about how BioMed's products can benefit their practices are encouraged to schedule a meeting during VMX 2024.
  • "We're excited to join VMX 2024 and connect with veterinary professionals," said Mitzi Rettinger, Chief Revenue Officer at DCN Dx.

Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X

Retrieved on: 
Tuesday, January 9, 2024
BioMed Central, Research

OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.

Key Points: 
  • OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.
  • For details, please refer to the following BioMed X press release and application guidelines for the research project:
    BioMed X's press release dated December 19, 2023:

Call for Application to Researchers for Joint Research Project between Ono Pharmaceutical and BioMed X

Retrieved on: 
Tuesday, January 9, 2024
BioMed Central, Research

OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.

Key Points: 
  • OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.
  • For details, please refer to the following BioMed X press release and application guidelines for the research project:
    BioMed X's press release dated December 19, 2023:

Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients

Retrieved on: 
Monday, January 8, 2024
Blood pressure, Bradycardia, Risk, Orchestra, Collection, Consultant, Hypertension, Mortality, Disease, HOPE, Stroke, Comorbidity, Patient, Safety, Heart failure, Beat (music), BioMed Central, OSBP, Pharmaceutical industry

AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce blood pressure.

Key Points: 
  • AVIM therapy is an investigational patented bioelectronic therapy, administered using a standard dual-chamber pacemaker, designed to immediately, substantially and persistently reduce blood pressure.
  • Orchestra BioMed and Medtronic, Inc. (NYSE: MDT) (“Medtronic”) formed a strategic collaboration for the development and commercialization of AVIM therapy for hypertensive pacemaker patients in July 2022.
  • Orchestra BioMed is actively screening patients for enrollment in the BACKBEAT pivotal study.
  • The study will randomize approximately 500 patients 1:1 to AVIM therapy combined with continued medical therapy (treatment) or continued medical therapy and standard pacing alone (control).